Resibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K/Akt signaling pathway-Reference-Cited by-同舟云学术

Resibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K/Akt signaling pathway

Published:2022-05-13 Issue:1 Volume:24 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Zhou Yan¹,Hong Zirui²,Jin Keting³,Lin Chenjun³,Xiang Jingjing⁴,Ge Hangping⁵,Zheng Zhiyin⁵,Shen Jianping⁵,Deng Shu⁵

Affiliation:

1. Department of Hematology, The First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China

2. The First Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China

3. The First Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China

4. Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China

5. Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference37 articles.

1. Multiple myeloma;Rollig;Lancet,2015

2. Patterns and predictors of first-line therapy use among newly diagnosed multiple myeloma patients ineligible for stem cell transplant in an integrated healthcare system;Rashid;Internet J Hematol,2014

3. Multiple myeloma: Every year a new standard?;Rajkumar;Hematol Oncol,2019

4. Multiple myeloma epidemiology and survival: A unique malignancy;Kazandjian;Semin Oncol,2016

5. Multiple Myeloma-current status in diagnostic testing and therapy;Kehrer;Z Orthop Unfall,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resibufogenin: An Emerging Therapeutic Compound with Multifaceted Pharmacological Effects – A Comprehensive Review;Medical Science Monitor;2023-12-27

2. E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma;British Journal of Haematology;2023-06-26